To match our flu peers (Biocryst, Novavax) on the Nasdaq our average volumes need to be maybe 300,000-500,000.
So far, it's 25,000.
Biocryst and Novavax have been listed on the Nasdaq for 20 years, while Bota are mere 6 months.
RP has a lot of work to do.